Enumera Molecular is a startup based in the United States, most recent round Series A, 1 tracked investor.
Enumera Molecular is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Enumera Molecular develops a simplified, rapid, and cost-effective molecular counting platform called EnumeraPlex to enable liquid biopsy and high-dimensional clinical molecular testing for laboratories.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.